Article Versions Notes

Mould RC, van Vloten JP, AuYeung AWK, Walsh SR, de Jong J, Susta L, Mutsaers AJ, Petrik JJ, Wood GA, Wootton SK, et al. Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin. Cancers. 2021; 13(24):6270. https://doi.org/10.3390/cancers13246270

Mould, Robert C., Jacob P. van Vloten, Amanda W. K. AuYeung, Scott R. Walsh, Jondavid de Jong, Leonardo Susta, Anthony J. Mutsaers, James J. Petrik, Geoffrey A. Wood, Sarah K. Wootton, and et al. 2021. "Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin" Cancers 13, no. 24: 6270. https://doi.org/10.3390/cancers13246270

Mould, R. C., van Vloten, J. P., AuYeung, A. W. K., Walsh, S. R., de Jong, J., Susta, L., Mutsaers, A. J., Petrik, J. J., Wood, G. A., Wootton, S. K., Karimi, K., & Bridle, B. W. (2021). Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin. Cancers, 13(24), 6270. https://doi.org/10.3390/cancers13246270